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Abstract. The capacity for long-distance migration of 
the oligodendrocyte precursor cell, oligondendrocyte- 
type 2 astrocyte (O-2A), is essential for myelin forma- 
tion. To study the molecular mechanisms that control 
this process, we used an in vitro migration assay that 
uses neurohypophysial explants. We provide evidence 
that O-2A cells in these preparations express functional 
N-mehtyl-D-aspartate (NMDA) receptors, most likely 
as homomeric complexes of the NR1 subunit. We show 
that NMDA evokes an increase in cytosolic Ca  2÷ that 
can be blocked by the NMDA receptor antagonist AP-5 
and by Mg  2÷. Blocking the activity of these receptors 
dramatically diminished O-2A cell migration from ex- 
plants. We also show that NMDA receptor activity is 
necessary for the expression by O-2A cells of the highly 
sialylated polysialic acid-neural cell adhesion molecule 
(PSA-NCAM) that is required for their migration. 
Thus, glutamate or glutamate receptor ligands may reg- 
ulate O-2A cell migration by modulating expression of 
PSA-NCAM. These studies demonstrate how interac- 
tions between ionotropic receptors, intracellular signal- 
ing, and cell adhesion molecule expression influence 
cell surface properties, which in turn are critical deter- 
minants of cell migration. 
URING development of the vertebrate brain, precur- 
sors of oligodendrocytes or oligodendrocyte-type 
2 astrocyte (O-2A) ~ cells migrate along nerve fi- 
bers, and this movement is essential for the process of my- 
elination (Lachapelle et al., 1984; Levison et al., 1993; Small 
et al., 1987; Kiernan and ffrench-Constant, 1993). While 
the capacity of O-2A cells to migrate over a long distance 
has been described extensively, the underlying cellular and 
molecular regulatory events are not well understood. Re- 
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suits from several studies suggest that growth factors such 
as PDGF and basic fibroblast growth factor may play an 
important role in O-2A cell migration (Noble et al., 1988; 
Richardson et al., 1988). PDGF provided by type 1 astro- 
cytes or by neurons is believed to maintain O-2A cells in a 
bipolar  migratory  state  and  to  guide  their  migration, 
whereas basic FGF appears to transform these cells into a 
nonmigratory multipolar form (McKinnon et al., 1993). In 
addition, PDGF appears to be a potent chemoattractant of 
O-2A cells (Armstrong et al., 1990). 
Apart from growth factors, adhesion molecules such as 
integrins (Milner and ffrench-Constant, 1994) and the neu- 
ral cell adhesion molecule (NCAM), in particular its poly- 
sialylated isoforms (Trotter et al., 1989; Wang et al., 1994), 
have also been implicated in O-2A migration. NCAM is 
known to serve as a homophilic receptor promoting cell- 
cell  adhesion  (Edelman,  1986). However, it  is  also  ex- 
pressed in an alternative form containing long chains of 
a2-8 linked polysialic acid (PSA) (Finne et al., 1983). PSA 
has been shown to convert NCAM into an antiadhesive 
agent (Rutishauser, 1992; Sadoul et al., 1983). The pattern 
of expression of PSA on NCAM is highly regulated during 
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tions is critical to a  variety of morphogenetic events in- 
cluding cell migration, transformation of cell shape, and 
axonal growth (Acheson et al., 1991; Doherty et al., 1992; 
Rougon et al., 1993). Consistent with this view, O-2A cells 
express  the  polysialylated isoforms  of NCAM,  whereas 
mature oligodendrocytes or type 2 astrocytes generated by 
these precursors exhibit the adult, less sialylated isoforms 
(Trotter et al., 1989; Wang et al., 1994). 
Recently, using an in vitro migration assay that consists 
of explants of newborn rat neurohypophysis, we have pro- 
vided direct evidence for the role of PSA on NCAM in O-2A 
cell migration (Wang et al., 1994). We have demonstrated 
that neurohypophysial explants from newborn rats gener- 
ate  cellular  outgrowths  in  which  virtually  all  migrating 
glial cells belong to the O-2A cell lineage (Wang et al., 
1994). Treatment of O-2A  cells with the  enzyme endo- 
neuraminidase (Endo N), which specifically removes PSA 
from the cell surface, produced a complete blockade of the 
dispersion of the O-2A cell population from the explant. 
This effect was reversible upon cessation of Endo N treat- 
ment (Wang et al., 1994). Since Endo N does not affect the 
protein core of the NCAM molecule, it is conceivable that 
it is PSA rather than NCAM itself that is essential for the 
migration of O-2A cells. Thus, one might expect that fac- 
tors that modulate the degree of sialylation of NCAM play 
a decisive role in O-2A cell motility. 
Recent studies suggest that calcium ion influx may have 
a critical role in PSA-NCAM expression in neurons, pan- 
creatic [3 cells (Kiss et al.,  1994), and myotubes (Rafuse 
and Landmesser, 1996). Ca  2÷ may also be involved in con- 
trolling  PSA  expression in  O-2A  cells.  Ca  2+  entry into 
neurons as well as glial cells can be mediated by ligand- 
gated ion channels such as glutamate receptors. Indeed, 
L-glutamate has been identified as an effective stimulus to 
trigger Ca  2+ influx in O-2A cell lineage cells (Fulton et al., 
1992;  Holzwarth  et  al.,  1994;  Kastritsis  and  McCarthy, 
1993; Pende et al., 1994). In vivo, O-2A cells migrate along 
axons  that  are  able  to release  glutamate  in  an  activity- 
dependent manner (Chiu and Kriegler, 1994), and it has 
been proposed that glutamate could act as a developmen- 
tal factor that regulates the migration as well as the prolif- 
eration of O-2A cells (Pende et al., 1994). The main gluta- 
mate receptor that controls Ca  2+ entry in neurons is of the 
NMDA type, and the NMDA receptor-mediated Ca  2÷ in- 
flux is thought to be involved in neuronal plasticity (Bliss 
and  Collinbridge, 1993)  and morphogenetic events  (Ko- 
muro  and  Rakic,  1993;  Scheetz and  Constantine-Platon, 
1994). 
In  the  present  study,  we  tested  the  hypothesis  that 
NMDA receptors are also present on O-2A cells and that 
Ca  2+  influx  plays  a  role  in  the  migration  process.  We 
present direct evidence for the existence of NMDA-type 
glutamate receptors in O-2A cells from previously charac- 
terized (Wang et al., 1994) neurohypophysial explants. We 
demonstrate that their blockade inhibits the migration of 
these cells. We also show that the activity of this receptor 
is necessary for the expression of PSA-NCAM, which is 
needed for the migration of O-2A cells. We thus provide 
experimental support for a role of NMDA-type glutamate 
receptor activity in O-2A cell migration and a basis for the 
underlying molecular mechanism. 
Materials and Methods 
Materials 
Recombinant, human PDGF (PDGF-AA homodimer form) and neuro- 
trophin-3 (NT3) were purchased from Boehringer Mannheim Biochemicals 
(Indianapolis,  IN) and Regeneron Pharmaceuticals  (Tarrytown,  NY), respec- 
tively. 2-D-L-aminophosphonovaleric  acid (d-AP5), the competitive antago- 
nist  of the  NMDA  receptor, and  6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX), the DL-et-amino-3-hydroxy-5-methyl-4-isoxazole  propionic acid 
(AMPA) and kainate receptor antagonist and NMDA, were purchased 
from  Tocris  Neuramin  (Bristol,  UK);  [+]-5-methyl-10,11-dihydro-5H- 
dibenzo [a,b] cyclohepten-5,10-imine maleate (MK-801), the noncompeti- 
tive NMDA receptor ionchannel blocker, was purchased from Research 
Biochemical Inc. (Natick, MA); the Na  + channel antagonist tetrodotoxin 
(TTX), the antagonist to the L-type voltage-sensitive Ca  2÷ channel nifed- 
ipin, cyclopiazonic acid that depletes IPa-sensitive Ca  2÷ stores without 
inhibiting L-channel activity (Nelson et al., 1994), and bromodeoxyurid- 
ine (BrdU) were purchased from Sigma Chemical Co. (St. Louis, MO). 
We used the enzyme Endo N, purified in our laboratory from phage K1 
(Wang et al., 1994). 
Neurohypophysial Explant Cultures and 
Migration Assay 
Explant cultures of the neurohypophysis were prepared from newborn 
(postnatal day 0) rats (Sprague-Dawley; Sivz, Ztirich, Switzerland) as de- 
scribed previously (Wang et al.,  1994). To avoid contamination by neu- 
roendocrine cells from the intermediate lobe and the adenohypophysis, 
the peripheral parts of the neurohypophysis were carefully eliminated. 
The  absence of such ceils in  our  preparations was  verified by immu- 
nostaining with antibodies directed against proopiomelanocortin-derived 
peptides. 
Cultures were maintained under three basic conditions: (a) in serum- 
free medium (Bottenstein, 1984) complemented with PDGF/NT3 (10 ng/ml); 
(b) in serum-free conditioned medium (Wang et al., 1994); and (c) in se- 
rum-complemented  medium (10% FCS; GIBCO BRL, Gaithersburg, MD). 
For the migration assay, cultures were divided into four groups: (a) 
controls maintained in serum-complemented  or serum-free medium for 3 d; 
(b)  as  (a)  with  the  addition  of different antagonists  and  agonists  of 
glutamate receptors and other ion channels; (c) serum-complemented me- 
dium with 3.5 mM Mg2+; (d) as (b) followed by an additional 3 d without 
antagonists. The extent of migration of O-2A lineage cells was assessed by 
counting the number of A2B5/glial fibrillary acidic protein (GFAP) (me- 
dium with serum) and O4/galactocerebroside GalC (serum-free medium) 
immunopositive cells present in the outgrowth after 3 d of culture (Wang 
et al., 1994) on at least four coverslips for each group in three to five inde- 
pendent experiments. 
Culture of Cortical Neurons 
Primary mixed cultures of neuronal and glial cells were prepared from 
newborn cerebral cortex as described (Kiss et al., 1994) and used for PCR 
amplification of mRNA encoding NMDA receptor subunits (NR2A-D) 
and intracellular free calcium measurements (see below) 7 d after plating. 
Antibodies and Immunocytochemistry 
A  rabbit polyclonal antibody (Ab) (Dakopatts, Copenhagen, Denmark) 
to GFAP was used (1:200  dilution) to identify astrocytes. Mouse mAb 
A2B5 hybridoma supernatant (American Type Culture Collection, Rock- 
ville, MD; 1:5 dilution) (Eisenbarth et al., 1979) and GD3 Ab (1:200 dilu- 
tion) (Curtis et al., 1988) specific to cell surface ganglioside epitopes were 
used to label O-2A progenitor cells. O4 mAb (hybridoma supernatant, 1:5 
dilution) (Eisenbarth et al., 1979) was used to identify undifferentiated 
oligodendrocytes and anti-GalC (Ranscht et aL, 1982) mAb (culture su- 
pernatant) for differentiated oligodendrocytes. Anti-PSA (Meningococ- 
cus group B [Men B]) is a mouse IgM Ab (1:400 dilution of ascites fluid) 
that recognizes specifically et 2-8-1inked PSA with chain length superior to 
12 residues (Hayrinen et al., 1995; Rougon et al., 1986). The rabbit antise- 
rum directed against the NCAM protein core was a site-directed Ab rec- 
ognizing the seven NH2-terminal residues of NCAM (1:1,000  dilution) 
(Rougon and Marshak, 1986). Rabbit anti-NMDAR1 is a polyclonal anti- 
serum (Chemicon Intl., Inc., Temecula, CA) that reacts with splice vari- 
ants NRI-la, NRI-lb, NR1-2a, and NR1-2b expressed in rat brain (1:100 
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anti-MAP2 mAb (1:200 dilution) (Sigma Chemical Co.) and proliferating 
ceils with an mAb directed to BrdU (Boehringer Mannheim Biochemi- 
cals) (1:50 dilution). 
For double labeling, Abs directed against surface antigens (PSA, NCAM, 
A2B5, 04, GalC) were applied onto live cells for 30 rain; cells were then 
fixed in cold (4°C) 4% paraformaldehyde in 0.1 M phosphate buffer, per- 
meabilized with a solution of PBS/0.5% BSA/0.3% Triton X-100, and in- 
cubated with the GFAP antibody for 1 h at room temperature. Bound an- 
tibodies were revealed with fluorescein-conjugated sheep anti-mouse Ig 
(dilution 1:80; Boehringer Mannheim Biochemicals) or rhodamine-conju- 
gated sheep anti-rabbit IgG (dilution  1:40; Boehringer Mannheim Bin- 
chemicals) secondary antibodies (diluted in PBS/0.5% BSA solution). For 
immunostaining with the anti-NR1  Ab, cultures were fixed with perio- 
date-lysine-paraformaldehyde (McLean's) fixative. Cultures were exam- 
ined with a fluorescence microscope (Axiophot; Zeiss, Oberlochen, Ger- 
many). Controls treated  with nonspeciflc mouse IgM,  IgG  preimmune 
sera, or secondary antibodies alone showed no staining. In double-immu- 
nolabeling experiments, the use of only one primary Ab followed by the 
addition of both anti-mouse FITC- and anti-rabbit TRITC-conjugated 
secondary antibodies resulted in only single labeling. Endo N  treatment 
completely abolished PSA immunostaining (see Fig. 2) without affecting 
NCAM or GFAP staining. 
lmmunocytochemical Assay of PSA Surface Expression 
To assess the relationship between NMDA receptor activity and PSA sur- 
face expression, neurohypophysial explants were maintained for 52 h  in 
serum-free medium complemented with PDGF (10 ng/ml) and NT3 (10 
ng/ml). Then the explants were removed, and the experiments were per- 
formed on the remaining cell population. Cells were treated with Endo N 
(0.5 U/ml) at 37°C for 1 h to remove preexisting PSA from the cell surface, 
as described (Wang et al., 1994).  After treatment, cultures were rinsed in 
serum-free medium containing 0.5% BSA and divided into three groups: 
(a) fixed immediately after the enzymatic treatment; (b)  allowed to re- 
cover either in serum-free medium with PDGF/NT3  or serum-comple- 
mented medium for 16 h; (c) as (b) with addition of d-AP5 (100 ~M) to 
the medium. An additional group (d) of cultures was maintained in se- 
rum-free medium in the presence of PDGF/NT3 for 2 d, and then incu- 
bated  in the presence or  absence of d-AP5  (100  p,M) for 5  d.  Subse- 
quently, all preparations were double labeled with anti-PSA/GFAP and 
anti-PSA/NCAM antibodies and examined with either an Axiophot mi- 
croscope (Zeiss) equipped with an epifluorescence device or a confocal la- 
ser scanning microscope system (MCR 600;  BioRad Microscience Ltd., 
Hertfordshire, UK) attached to an Axiophot microscope. The laser source 
was a krypton/argon mixed gas laser that emits three strong beams of light 
in exact coalignment at wavelengths of 488, 568, and 647 nm (model 5425; 
Ion Laser Technologies, Salt Lake City, UT). To avoid any interference in 
fluorescence emission, FITC and TRITC images of double-labeled cells 
were taken consecutively. 
Quantitation of PSA surface fluorescence was performed using confo- 
cal microscopy and the Comos software package, version 4.62 (BioRad 
Microscience Ltd.), as described (Kiss et al., 1994). Briefly, cells double la- 
beled for PSA and NCAM or PSA and GFAP were randomly sampled on 
the basis of NCAM or GFAP staining (TRITC) using a x63 oil immersion 
Plan-I objective.  Images of PSA (FITC)  of each selected cell were col- 
lected (5-10 cells for each culture). The intensity of fluorescent excitation 
of ceils, gain, and black levels were kept constant for each session of mea- 
surement. Fluorescent intensity was measured by random sampling of the 
cell surface using a frame of 12 x  8 pixels (2.28 ×  1.52 I~m). Five indepen- 
dent measures of peak intensities were recorded and averaged for each 
cell. The pixel intensity threshold was adjusted so that the background 
corresponded to level O  (maximum in arbitrary units was 255). The peak 
intensities measured over individual O-2A-like cells were averaged for 
each culture, and then normalized to those obtained from group 1 cultures 
(fixed immediately after the treatment of Endo N) that had been pro- 
cessed in the same experiment and measured in the same session. 
Bromodeoxyuridine Incorporation In Vitro 
BrdU (Sigma Chemical Co.) was added to cultures at a final concentration 
of 10 IxM. Explants were fixed in 70% ethanol at 41°C for 2 h, treated with 
1 N HCI for 15 min to denature the DNA, and double labeled with anti- 
BrdU mAb and anti-GFAP polyclonal Ab, as described above. 
In Situ Hybridization 
Oligonucleotide probes complementary to the mRNAs encoding gluta- 
mate receptor subunits were selected on the basis of the cloned eDNA se- 
quences and synthesized on a DNA synthesizer (394; Applied Biosystems, 
Foster City, CA). The NR1 probe is complementary to a sequence encod- 
ing amino acid (aa)  residues 566-580 of the mature NR1  polypeptide, 
NR2A (aa 567-579), and NR2B (aa 557-572). They were 3'-end labeled 
by incubation with [35S]deoxy-ATP (New England Nuclear, Boston, MA) 
and terminal deoxynucleotidyl transferase (Pharmacia Fine  Chemicals, 
Piscataway, NJ)  to attain specific activities of ~5-8  ×  108 cpm/l~g. The 
specificity of the probes has been previously described  (Monyer et al., 
1992). Explant cultures of the neurohypophyses maintained in serum-free 
medium in the presence of PDGF and NT3 for 3 d were rinsed in PBS, 
fixed in 4% paraformaldehyde, and processed for in situ hybridization as 
described previously (Bartanusz et al., 1993).  After an overnight hybrid- 
ization at 41°C, cultures were washed successively in 4 ×, 1 x, and 0.1  × 
SSC, quickly dehydrated in ethanol (70%), and air dried. Autoradiogra- 
phy was achieved using NTB3 emulsion (Eastman Kodak Co., Rochester, 
NY), and slides were exposed 4-5 wk at 4°C. Analysis of in situ hybridiza- 
tion  autoradiographs was  accomplished on hematoxylin-eosin-counter- 
stained sections. No in situ hybridization signal was detected in cultures in 
the presence of an excess amount (50-fold) of unlabeled probes. Further- 
more, the specificity of all probes has been controlled as to their distinct 
cellular pattern of expression throughout the rat brain within the same ex- 
periments. 
PCR Amplification of mRNA Encoding NMDA 
Receptor Subunits and Southern Blot Analysis 
Extraction of RNA. Total RNA was isolated from neurohypophysial ex- 
plants, cells in the migratory pool, and primary cultures of cortical neu- 
rons using RNAzol B (Cinna/Biotecx Laboratory, Inc., Houston, TX) con- 
taining  guanidium  thiocyanate  and  phenol,  as  previously  described 
(Chomczynski and Sacchi, 1987). cDNA was synthesized using the reverse 
transcriptase (Promega, Madison, WI) system. The enzyme was heat de- 
natured at  95°C for 5  min. Amplification of DNA sequences was per- 
formed essentially as described (Saiki et al., 1988).  Briefly, 6 Ixl of eDNA 
template were added to a reaction mixture containing 10 mM Tris-HCl, 
0.1 mM EDTA, 1 mM DTT, 100 mM KC1, 0.1% Triton X-100, 0.2 mM 
dNTP, 0.2 mg/ml activated DNA, 0.2 mM of each primer (sequences are 
given below), and 12.5 U of DNAzyme (Finnzymes OY, Espoo, Finland) 
in a  total volume of 50 ixl. Amplification conditions were: 30 cycles of 1 
min at 95°C, 1.5 min at 62°C, and 1.5 min at 72°C, followed by a final ex- 
tension step at 72°C for 7 min. 
Primer sequences: NR1-PCRI: 5'CATGGCGAAACCAGCCCACAC- 
CAT  (corresponds  to  aa  634--641);  NR1-PCR2:  5'GGAGTGGAA- 
CGGAATGATGGGCGAG (corresponds to aa 495-504); NR2A-PCRI: 
5'CAATCTGACTGGATCACAGAGC  (corresponds  to  aa  887-893); 
NR2A-PCR2: 5'CTGTCCTTCCCTrGAAAGGATC (corresponds to aa 
947-951); NR2B-PCRI: 5'CAATAACCCACCCTGTGAGG (corresponds 
to aa 948-956); NR2B-PCR2: 5'GGTGGGTrGTCACAGTCATAG (cor- 
responds to  aa  1,016-1,022);  NR2C-PCRI:  5'CCATFCTGGCCCTCG- 
GTGCCC (corresponds to  aa 308-314);  NR2C-PCR2:  5'TTAGATCC- 
CCGCTGCTGAAGG  (corresponds  to  aa  453-460);  NR2D-PCRI: 
5'GGTGGTGGCCAGAGGTGCCC (corresponds to aa 322-329); NR2D- 
PCR2: 5'GATGCAAGTGCCGCTGATGG (corresponds to aa 447-454). 
Southern Blot Analysis. PCR reaction products were analyzed on a 1% 
agarose gel, and DNA bands were visualized by ethidium bromide stain- 
ing. After electrophoresis, DNA fragments were transferred onto nitro- 
cellulose  membranes (Schleicher  &  Schuell, Keene, NH)  as  described 
(Sambrook et al., 1989) and hybridized with the following oligonucleotide 
probes, labeled at the 5' end with T4 polynucleotide kinase (Boehringer 
Mannheim Biochemicals). 
Hybridization was performed at 42°C, overnight in 6 ×  SSC, 5 ×  Den- 
hardt's, 0.5% SDS and 100 ixg/ml denatured salmon sperm DNA, and 2 × 
106 cpm 32P-labeled probes. After hybridization, membranes were washed 
for 2 h at 42°C, followed by 20-min washes at 50  °, 55  °, and 60°C.  Autora- 
diography was done on x-ray films (XAR; Eastman Kodak Co.). 
Sequences of the probes used for Southern blotting are as follows: 
NR-I:  (see  in  situ hybridization);  NR-2A:  5'GTAGCTCTITI'AGGT- 
GAGTCC  (corresponds  to  aa  915-921);  NR-2B:  5'CCITCAGCTG- 
CAGGTTACC (corresponds to aa 979-976); NR-2C: 5'ACAGGACTC 
CATGGTCCCACCGTCCC (corresponds to aa 384-393); NR-2D: 5'CCA- 
GTGAAGGGTFCACCAGAAAGCC (corresponds to aa 375-384). 
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Membrane currents were  recorded  with  the patch-clamp technique in 
whole-cell configuration with an axopatch 200A amplifier (Axon Instru- 
ments, Inc., Budingame, CA). Patch electrodes were pulled from thick- 
walled horosilicate glass (Clark Electromedical Instruments, Pangbourn, 
UK) and had an open resistance of 4-7 Mfl. The access resistance after 
breaking the patch was below 10 MII, otherwise the cell was rejected. Se- 
ries resistance compensation was always used and set to 85%. The cells 
were continuously perfused, permitting application of drugs. Current and 
voltage traces were sampled at 50 Hz or 1 KHz by an interface (SICMU) 
connected to an IBM computer and stored on its hard disk. All recordings 
were performed at 22°C. 
The external medium had the following composition (mM): 154 NaC1, 
5 KC1, 2 CaCl2, 0.1 MgC12, 5 glucose, and buffered with 10 Hepes. pH ad- 
justment to 7.4 was obtained with NaOH. Pipettes were filled with a solu- 
tion containing (raM): 120 KCI, 33 KOH, 2 MgCl2, 0.1 CaCl2, 2 MgATP, 
and 11 EGTA. In the Cs+-containing solution, KC1 and KOH were substi- 
tuted with CsCI and CsOH. 
IntraceUular Free Calcium Measurements 
Cultures were loaded with fura-2 acetoxymethyl ester (1 p~M final concen- 
tration) for 30 min at 37°C in culture medium. Ratiometric measurement 
was performed in a  new spectrofluorimeter Specsys  ® developed at  the 
Geneva University Medical Centre (Geneva, Switzerland). The excitation 
source is provided by a  xenon lamp coupled to quartz light guides and 
pairs of synchronous spinning wheels that allow the excitation and emis- 
sion wavelengths to be changed. For fura-2 assessment, 340/510-nm and 
380/510-nm pairs were  selected. The coverslips with cultures of neural 
lobe explant were sealed with silicon grease over the central hole of a petri 
dish that served as a superfusion chamber installed on an inverted micro- 
scope  (F-100;  Nikon Inc., Garden  City, NY).  Cells were  observed and 
monitored in the epifluorescence mode. The emitted light was cut off at 
N400 nm and directed into a high sensitivity photomultiplier tube kept re- 
frigerated at 9°C. UV intensity of the excitation light was adjusted by a 
specific diaphragm to prevent unnecessary cell irradiation. Signals from 
the photomultiplier were digitized and computer processed. The prepara- 
tions were continuously superfused (1 ml/min) at 37°C with the following 
modified Krebs-Ringer bicarbonate salt solution buffered with Hepes and 
gassed with air (mM): 158 NaC1, 5.6 KCI, 2.5 CaCI2, and 5 NaHCO3; when 
not indicated, MgCl2 was 0.5; Hepes, 10.0; glucose, 10.0; pH 7.4. Stimulat- 
ing solutions were introduced by side-infusion through a micropipette (in- 
ternal diam ~50 p~m) placed in the vicinity of the cell under study, as al- 
ready described (Pralong et al., 1990). 
Results 
Neurohypophysial O-2A cells are bipotential precursors that 
can give rise to either oligodendrocytes or type 2 astrocytes, 
depending on  the  factors present  in  their  environment 
(Wang et al., 1994). If explant cultures were maintained in 
serum-free medium complemented with NT3/PDGF (10 
ng/ml), the differentiation of O-2A  precursors was pre- 
vented (Barres et al.,  1994). This allowed us to obtain a 
large number of migrating and proliferating O-2A  cells 
around the explant (Fig. 1, A and B, and Fig. 2 A). These 
cells were immunostained with antibodies against estab- 
lished  markers  of  oligodendrocyte  precursors  such  as 
A2B5 (Fig. 1 A), GD3 (Fig. 1 B), 04 (Fig. 2 G), and PSA- 
NCAM  (see Fig. 6).  The percentage of A2B5/GD3/O4- 
positive cells varied from experiment to experiment, rang- 
ing from 80-95%  of the  total migrating population.  In 
these  preparations,  MAP2-  or  neurofilament-  (neuron- 
specific markers) positive cells could not be detected (data 
not shown), which is consistent with the notion that there 
are no neurons in the neurohypophysis in vivo (Hatton, 
1990). When the precursor cells were allowed to differenti- 
ate in serum-free conditioned medium (without PDGF/ 
NT3), GalC+ oligodendrocytes became detectable (Fig. 1, 
C and D). In contrast, in serum-containing medium, type 2 
astrocytes but no oligodendrocytes were discernible in the 
migratory pool (Fig. 1, E and F; see Fig. 8). We have previ- 
ously demonstrated that under this condition, virtually all 
GFAP +  astrocytes display A2B5 immunoreactivity, and 
thus belong to the O-2A lineage (Wang et al., 1994). In all 
three conditions, the migrating cells were the O-2A pro- 
genitors; type 2 astrocytes and oligodendrocytes were not 
motile (Small et al., 1987). 
Presence  of  NMDA Receptor Subunit RNA and Protein 
Immunoreactivity in Cells of the O-2A Lineage 
The NMDA receptor is a pentameric transmembrane pro- 
tein that is composed of different subunits (Moriyoshi et al., 
1991; Seeburg et al.,  1995). Five known receptor subunit 
genes have been identified and sequenced (Moriyoshi et al., 
1991; Seeburg et al., 1995). The NR1 subunit is essential 
for function, while members of the NR2 subunit class, pro- 
duced by four different genes (NR2A-NR2D), can be con- 
sidered modulatory (Moriyoshi et al., 1991; Seeburg et al., 
1995).  We first assayed for the  presence  of NR1  RNA 
transcripts  and  immunoreactivity in  neurohypophysial 
O-2A cells using in situ hybridization analysis, immunocy- 
tochemistry, and analysis of the NR1 transcripts by reverse 
transcriptase  followed  by  sequence  amplification  (RT- 
PCR). The last approach was also used to assay for the 
presence of NR2A-D RNA transcripts. Neurohypophysial 
cultures were kept in serum-free medium complemented 
with NT3/PDGF (10 ng/ml) for 3 d. To delineate the cellu- 
lar origin of NR1 subunit mRNA, in situ hybridization was 
performed using 35S-labeled NRl-specific oligonucleotide 
probes (Fig. 2, B and C). An accumulation of silver grains 
was observed over most cells with thin processes and a bi- 
polar or multipolar morphology (Fig. 2 B). There was no 
signal  on  large  epitheloid  cells,  presumably  fibroblasts 
(Fig. 2 B), or on pure fibroblast cultures that were pro- 
cessed concomitantly with neurohypophysial cultures (not 
shown).  Control  hybridization with  excess  amount  (50- 
fold) of unlabeled probe gave no signal (Fig. 2 C). These 
results  strongly suggested  that  the  NR1  subunit  of the 
NMDA  receptor was present in  O-2A  cells. Additional 
support for this conclusion was provided by the results of 
immunocytochemical analysis using a polyclonal NRl-spe- 
cific Ab. NR1 immunoreactivity was localized specifically 
on process-bearing A2B5+ (Fig. 2, D-F) or 04+ (Fig. 2 G 
and/) cells.  Some of these cells were negative for NR1. 
We have never observed NR1 immunostaining in A2B5-/ 
04-  cells (e.g., in fibroblasts)  (Fig. 2, D-/).  Thus, NR1 
subunit expression in these cultures appears to be exclu- 
sive to cells of the O-2A lineage. 
The presence  of NRl-specific mRNA was further as- 
sessed by PCR amplification using NRl-specific primers. 
After 6 d in vitro, explants and the cellular outgrowths were 
harvested separately (see Materials and Methods). eDNA 
was then synthesized from total RNA. Results shown in 
Fig. 3 1 demonstrate the presence in both explants and mi- 
grating cells of an amplified DNA fragment with a  size 
corresponding to that predicted from the NR1 mRNA se- 
quence (Fig. 3 I, A). Further analysis of the fragments by 
Southern blotting using a labeled NRl-specific probe (Fig. 
3 I, B) and by restriction enzyme digestion (not shown) 
The Journal of Cell Biology, Volume 135, 1996  1568 Figure 1.  O-2A lineage cells in the cellular outgrowth of neurohypophysial  explants. (A and B) A2B5 (A) and GD3 (B) immunostained 
O-2A cells generated in serum-free medium complemented with PDGF/NT3 (10 ng/ml). These cells also exhibit 04 (see Fig. 2 G) and 
PSA-NCAM (see Fig. 6) immunoreactivity,  but not that of GFAP and the neuronal marker MAP2. (C and D) GalC-positive oligoden- 
droeytes after 3 d in serum-free conditioned  medium without PDGF/NT3. (E and F) A2B5/GFAP immunoreactive type 2 astroeytes af- 
ter 3 d in serum-complemented medium. Bars: (A-D) 75 Ixm;  (E and F) 30 p~m. 
confirmed that the amplified DNA fragments were identi- 
cal  to  those  obtained  from cortical  neurons  (Fig.  3  I/). 
From  these  results,  we  infer  that  explant  and  migratory 
cells contain NRl-specific mRNA. 
We also investigated whether O-2A cells were express- 
ing mRNA encoding NR-2A and NR-2B subunits  of the 
NR-2 class.  Results  of in  situ  hybridization  (not  shown) 
and RT-PCR amplification (Fig. 3 I/) were negative for ei- 
ther mRNA in the neurohypophysis, whereas both mRNAs 
were easily detected in rat brain sections (not shown) or 
cultures of cortical neurons (Fig. 3 I/) used as positive con- 
trols.  RT-PCR  amplification followed by Southern  blot- 
ting was finally performed to explore for the presence of 
mRNAs encoding  NR-2C  and  NR-2D  subunits.  Neither 
mRNA could be detected in explants or in migrating cells 
(data not shown). These results suggest that O-2A cells express 
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mRNA  encoding  the  NR1 
subunit of the NMDA recep- 
tor  in  neurohypophysial ex- 
plants,  cDNA  synthesized 
from  total  RNA  isolated 
from  explants and  from mi- 
grating cells was used for the 
amplification  by  PCR  of 
NR1  sequences, using oligo- 
nucleotide  primers  PCR1 
and PCR2 (see Materials and 
Methods).  Amplified  frag- 
ments  were  then  analyzed 
on a 1% agarose gel followed 
by  Southern  blotting.  (A) 
Ethidium  bromide  staining 
of NRl-specific PCR-ampli- 
fied fragments  from  cells in 
explants (lanes 1 and 3) and 
from migrating ceils (lane 2). 
(Lane  4)  Control  amplifica- 
tion in the absence of prim- 
ers.  (B)  Results of a  South- 
ern  blotting  of  DNA 
amplified with  NRl-specific 
oligonucleotide  primers. 
DNA fragments were  trans- 
ferred  onto  nitrocellulose fil- 
ters and  hybridized with 32p. 
labeled NRl-specific oligonu- 
cleotides (see Materials and 
Methods). (Lanes 1--4) Same 
as in A.  (I/) Analysis of the 
presence of NR1, NR2A, and 
NR2B  subunits  of  NMDA 
receptors in NH explant cul- 
tures using PCR amplification. 
NRI-,  NR2A-,  and  NR2B- 
specific oligonucleotide prim- 
ers (see Materials and Meth- 
ods) were used in PCR  am- 
plifications  on  cDNA  from 
explant cultures of NH  and 
cortex  (CTX;  positive  con- 
trol).  (Lanes  1-4) PCR  am- 
plifications using NR1, NR2A, NR2B  primers, and no cDNA, respectively. (A) Ethidium bromide staining of PCR amplified frag- 
ments. (B-D) Results of Southern blots using 32p-labeled oligonucleotide probes specific for NR1, NR2A, and NR2B, respectively. 
mRNA corresponding to the NR1 subunit but none of the 
other subunits (NR2A-D) known to be present in neurons. 
Patch-Clamp Recordings 
To demonstrate that NMDA  receptors in O-2A cells are 
functional, we have performed a  series of whole-ceU patch- 
clamp recording experiments on cultures maintained in se- 
rum-free medium with or without PDGF/NT3.  The  cells 
included in the study were small unipolar or bipolar cells 
with thin processes. They were close (within 20 Ixm) to the 
explant, and some still attached to it with a  process. The 
mean cell capacitance determined by proper cancellation 
of the capacitive transient artifacts was in the range of 2.5- 
Figure 2.  Localization in O-2A cells of mRNA and protein immunoreactivity for the NR1 subunit. (A) Overview of an explant culture 
maintained in serum-free medium supplemented with PDGF and NT3 (10 ng/ml). Under these conditions, the percentage of bipolar or 
multipolar A2B5/O4-positive O-2A-like cells varies from experiment to experiment, ranging from 80-95% of the total migrating cell 
population. (B) In situ hybridization labeling associated with bipolar O-2A-like cells. Notice that there is no specific labeling over epi- 
theloid fibroblast-like  cells (arrow). (C) No specific hybridization signal is seen in the presence of a 50-fold excess of unlabeled oligonu- 
cleotide probe. (D-/) NR1 immunostaining (E and/at) in A2B5-positive (D) and O4-positive (G) O-2A cells. Antibody binding was vi- 
sualized with an FITC-labeled secondary antibody. The A2B5-positive cell (arrowhead) and fibroblast-like cells (arrows) are negative. 
Bars: (A) 100 ~Lm; (B and C) 10 ~m; (D-F) 20 Ixm; (G-/) 30 g.m. 
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Figure 4.  NMDA current in 
the glial precursor cells. (A) 
Typical  pattern  of  voltage- 
activated currents  in  a  glial 
precursor cell. Starting from 
a  holding  potential  of  -80 
mV (Vh), the membrane was 
stepped for 100 ms to poten- 
tials ranging from  -120 mV 
to +40 mV by 20-mV incre- 
ment pulses. (B) Current ac- 
tivated by a 20-s application 
of NMDA  (50 izM) from  a 
V h of -70 mV (same cell as 
in A). (C) Currents activated 
by  kainate  (100  I~M) and 
NMDA (50 ~M) application 
at various Vh recorded with a 
Cs+-containing  pipette.  Vh 
was changed at least 30 s be- 
fore drug application and is 
indicated beside each  trace. 
The  two horizontal bars for 
each  potential  indicate  the 
period  of  kainate  (K)  and 
NMDA  (N)  application, re- 
spectively.  The  trace  was 
split, and only the drug appli- 
cation  periods  are  shown. 
Each trace was offset on the 
base line (dotted line). (D) I/ 
V  curves of the kainate and 
NMDA  current  (n  =  4) 
shown in C. The NMDA cur- 
rent  has  a  marked  decrease 
at  hyperpolarized potential. 
(E) Mg  2+ block at hyperpo- 
larized  potential.  NMDA 
was applied on a  cell in the 
presence  (2  rnM) and  ab- 
sence  of  Mg  2+  (Vh  =  --80 
mV).  (F)  Blockade  of  the 
NMDA  current  by MK-801 
(10  ixM).  NMDA  was  ap- 
plied before and 3 min after 
MK-801  application.  The 
horizontal bars on the top of 
the trace indicate the  appli- 
cations of NMDA  with  the 
corresponding concentration. 
MK-801  resulted  in  a  com- 
plete  block  of  the  NMDA 
current. 
10 pFa (7.7  pFa  ---  1.7;  n  =  25),  which corresponds to a 
sphere of ~ll-~m  diam. In KCI recording solution, these 
cells displayed the typical pattern of voltage-activated cur- 
rents of the O-2A glial precursors (Fig. 4 A) (Barres et al., 
1990; Blankenfeld et al., 1992). The principal current was 
an outwardly rectifying K + current, both of the non-deac- 
tivating and the deactivating type. A  q-TX-sensitive Na  ÷ 
current was recorded in about half of the cells, and about 
a third expressed a small highly Ba2+-sensitive inward recti- 
fier  current.  To  assay  for  NMDA  receptors,  the  ligand 
NMDA  (50 txM) in the presence of 100 IxM external Mg  2+ 
was added to the external solution. On all 14 cells tested, 
NMDA  activated an inward current (Fig. 4 B) at V h (-70 
mY) in the range of 20-100 pA (50.5 pA _+ 13) that slowly 
inactivated upon prolonged application. To avoid desensi- 
tization, repetitive applications were done at intervals of at 
least 30 s. Responses could be obtained with 5 ~M NMDA 
and maximized around 100 IxM (data not shown). In Fig. 
4 C, we present a typical recording where both kainate and 
NMDA  were applied to the same cell that was recorded 
with a  Cs+-containing pipette solution. Fig. 4  D  demon- 
strates that the IN  curve obtained from the cell shown in 
Fig. 4  C  displayed the typical block in the hyperpolarized 
potentials  (Mayer and  Westbrook,  1987).  Some  degree 
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Figure 5.  Changes in [Ca2+]i in fura-2-1oaded  O-2A cells evoked 
by NMDA stimulation:  effects of the receptor antagonist  d-AP5, 
extracellular  Mg  2+ addition,  or extracellular  Ca  2÷ omission. (A) 
Inhibition  of NMDA-induced  (50  I~M) [Ca2+]i  rise  by d-AP5 
(AP5; 100 IxM) and high extracellular  Mg  2÷ (3.5 mM) tested se- 
quentially  on the  same cell. (B)  Effects of extraceUular  Ca  2÷ 
omission (Ca2+-free, nominally free + 100 p,M EGTA) on NMDA- 
evoked  Ca  2+  rise  and  comparison  with  the  receptor  agonist 
glutamate (25 ixM). When not indicated,  NMDA is applied si- 
multaneously with nominally free Mg  2+  +  100 txM glycine. We 
noticed that prolonged preperifusions with glycine tended to de- 
sensitize the NMDA-induced responses.  The traces shown in A 
and B are representative  of at least five independent  experiments. 
of rectification  in  the  hyperpolarized  range  was  always 
present, although it was highly variable. The current am- 
plitude was systematically smaller at -80 mV than at -40 
mV, and the mean ratio of I(-80)/1(-40) was 0.76  +_ 0.2 
(mean  +_  SD, n  =  5). This block could,  however, be re- 
lieved by omitting Mg  2÷ in the superfusate (see Fig. 4 E). 
The current in the absence of Mg  2+ was increased by a fac- 
tor of 2.3  --_ 0.8 (n =  4) as compared with that recorded in 
the 2 mM Mg  2+ solution. Fig. 4 F shows that the NMDA 
current  was completely abolished by MK-801.  These re- 
suits,  i.e.,  the range of the  activating concentrations,  the 
block by MK801,  and the Mg2+-sensitive rectification of 
the I/V curve in the hyperpolarized potentials, show con- 
clusively that  the  application  of the  ligand  NMDA  on 
O-2A precursors  activates a  current  that  has similarities 
with the neuronal NMDA current. 
IntraceUular Calcium Measurements 
Since  NMDA  receptors  are  known  to be  permeable to 
Ca  2+, we tested whether changes in free intracellular Ca  2+ 
concentrations ([Ca2+]i)  could be induced in fura-2-1oaded 
O-2A-like cells by NMDA (Fig. 5). Explants used for this 
study  were  maintained  in  serum-free  medium  with  or 
without PDGF/NT3. NMDA application on a typical bipo- 
lar  migrating  cell,  together  with  glycine  (100  IxM)  in  a 
Mg2÷-free medium, caused an immediate elevation of in- 
traceUular free Ca  2÷ (Fig. 5 A). The specificity of the re- 
sponse was demonstrated by the application of the NMDA 
receptor antagonist d-AP5  (100  IxM) that obliterated re- 
versibly and  completely the  [Ca2+]i  rise  caused  by  the 
NMDA stimulation. Perifusion with high Mg  2÷ had similar 
effects as demonstrated on the same cell. To test whether 
NMDA  did  not  cause  primarily an  elevation  of  [Ca2+]i 
through the mobilization of Ca  2÷ from intracellular Ca  2÷ 
stores, NMDA was applied in the absence of extracellular 
Ca  2÷ (Fig. 5 B). Under such conditions, no NMDA-evoked 
[Ca2+]i rise was observed. Readdition of extracellular Ca  2+ 
resulted in the restoration of the NMDA-induced  [Ca2+]i 
elevation. As a control, 25 p~M glutamate, a concentration 
known to stimulate NMDA receptors preferentially, was 
tested on the same cell. This maneuver caused a  similar 
Ca  2÷ increase as observed previously with NMDA (Fig. 5 
B).  It is noteworthy that the proportion of cells demon- 
strating NMDA-evoked [Ca2+]i responses varied from cul- 
ture to culture (20-50%  of tested cells) and displayed dif- 
ferent response patterns. The NMDA-evoked response was 
in general of smaller amplitude (A [Ca2+]i <250 nM) than 
that evoked in cortical neurons in primary culture tested 
under  the  same  conditions  (A  [Ca2+]i  ~400  nM;  not 
shown). Taken together, these observations are consistent 
with the view that activation of functional NMDA recep- 
tors on migrating O-2A-like cells generates small [Ca2÷]i 
elevations that arise primarily from Ca  2+ influx. 
The Pharmacological Blockade of NMDA 
Receptors Inhibits the Expression of PSA-NCAM in 
O-2A Lineage Cells 
We  then  tested  whether  NMDA  receptor  activity  was 
linked to PSA-NCAM expression in O-2A cells. We used 
a  previously described  experimental strategy to  explore 
this possibility (Kiss et al., 1994). O-2A cells were allowed 
to migrate in the presence of NT3/PDGF for 52 h; the ex- 
plant was then carefully removed to prevent further out- 
growth, and the remaining population of cells was treated 
with Endo N  to remove PSA from their surface. Cultures 
were allowed to recover in either serum-complemented or 
serum-free medium (with NT3/PDGF) in the presence or 
absence of d-AP5 (100 IxM), and then were fixed and dou- 
ble immunostained for PSA/GFAP or PSA/NCAM. Fig. 6, 
A  and B, illustrates the localization of PSA and NCAM 
immunostaining in  O-2A  cells.  Endo  N  treatment  com- 
pletely removed PSA immunoreactivity from the cell sur- 
face (Fig. 6, C and D). An initial series of experiments al- 
lowed  us  to  establish  that  PSA  staining  recovered 
significantly 16 h  after removal of the enzyme (Fig. 6, E 
and F). Hence, we used this time point for the quantitative 
analysis of PSA surface staining. Fig. 6, G-l, shows that 
the  pharmacological blockade  of NMDA  receptors by 
d-AP5  inhibited  PSA  recovery on  the  surface  of O-2A 
cells by ~90%  compared with  controls.  This  effect was 
identical in the presence or absence of serum. PSA recov- 
ery was not influenced by depolarizing conditions (in the 
presence of 50 mM K+). Thus, the pharmacological block- 
ade of NMDA receptors prevents the reexpression of PSA 
on the O-2A cell surface after Endo N treatment. 
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Figure  6.  Recovery of PSA 
immunoreactivity on the sur- 
face  of  neurohypophysial 
O-2A  cells  after  Endo  N 
treatment  as  evaluated  by 
quantitative confocal micros- 
copy. Cultures maintained in 
serum-free  medium  with 
PDGF/NT3  for  52  h  were 
treated with Endo N for 1 h, 
rinsed, allowed to recover in 
the  absence  or  presence  of 
100 I~M d-AP5 for 16 h, and 
then  double  immunostained 
for PSA and NCAM. (A and 
B)  PSA-NCAM  immuno- 
staining in a  control culture. 
(C  and  D)  Cells  fixed  and 
double  immunostained  im- 
mediately  after  Endo  N 
treatment.  Notice  that  PSA 
immunoreactivity  has  virtu- 
ally  disappeared,  whereas 
NCAM  immunostaining  is 
not affected by the treatment. 
(E  and  F)  Endo  N-treated 
cells were allowed to recover 
for  16  h  in  serum-free  me- 
dium  complemented  with 
PDGF/NT3.  Cells display an 
intense  PSA  staining.  (G 
and  H)  This  recovery  is  al- 
most  completely  blocked 
with  d-AP5  treatment.  (E) 
PSA  surface  staining  was 
evaluated  by  quantitative 
confocal  microscopy  as  de- 
scribed  in  Materials  and 
Methods.  The  results  show 
relative  values  in  arbitrary 
units (means _+ SEM of n  =  3 
independent  experiments 
from  110  cells),  normalized 
to that obtained at the end of 
Endo N treatment (group 1). 
Bars, 30 ~m. 
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long-term blockade of NMDA receptors would also down- 
regulate PSA on O-2A cells. To test this hypothesis, O-2A 
ceils were allowed to migrate in serum-free medium com- 
plemented with PDGF and NT3 for 2 d, and then further 
cultured in the presence or absence of 100 IxM d-AP5 for 
5 d. The antagonist produced a dramatic decrease in PSA 
staining on the surface of O-2A cells compared with con- 
trois  (Fig.  7).  Interestingly, NCAM immunostaining was 
not  influenced  by the  treatment.  Other  features such  as 
cell shape or A2B5 immunoreactivity were not influenced 
by d-AP5. The addition of an AMPA receptor channel an- 
tagonist, CNQX (10 IxM), to the medium was without ef- 
fect (not shown). These experiments indicate that the ac- 
tivity of the NMDA receptor is required for PSA but not 
for NCAM expression on O-2A cells. 
Antagonists to the NMDA Type of Glutamate 
Receptors Block the Migration of O-2A Lineage Cells 
from Neurohypophysial Explants 
The migration of O-2A-like cells from neurohypophysial 
explants critically depends on the presence of PSA-NCAM 
(Wang et aI., 1994). We thus tested the role of NMDA re- 
ceptor activation in the regulation of this process. Cell mi- 
gration was assayed under two conditions:  in serum-con- 
taining medium and in serum-free medium without growth 
factors. O-2A cells were allowed to migrate for 3 d and to 
differentiate into type 2 astrocytes or GalC+ oligodendro- 
cytes either in the presence or absence of antagonists to 
NMDA or non-NMDA receptors, and then were fixed and 
processed  for immunocytochemistry. O-2A  lineage  cells 
have been identified on the basis of their double immuno- 
staining with anti-A2B5 and -GFAP Abs (Raft, 1989) (se- 
rum-containing  medium)  or with  anti-GalC Ab  (serum- 
free  medium),  and  migration  was  assessed  by counting 
cells in the zone of the cellular outgrowth. In the presence 
of  serum  without  antagonists,  ~50-60  GFAP+/A2B5+ 
cells were detected around each explant (Fig. 8); this num- 
ber is significantly lower than that in serum-free medium 
with PDGF/NT3. Migration was dramatically inhibited by 
blocking NMDA receptors either with d-AP5 (100 IxM), a 
competitive antagonist, or by the noncompetitive antago- 
nist, MK-801  (1  IxM)  (Fig. 8 E). These effects were dose 
dependent (Fig. 8 F). Inclusion to the culture medium of 
20  I~M  CNQX  caused  a  significantly  weaker  inhibition 
(Fig. 8 E). Negligeable effects were observed after the ap- 
plication of the Na  ÷ channel antagonist TTX (1  IxM), the 
antagonist to the L-type voltage-sensitive channels nifed- 
ipin (10 IxM), and cyclopiazonic acid (10 IxM) that depletes 
IPa-sensitive Ca  2÷ stores (Fig. 8 E). Importantly, the pres- 
ence of NMDA receptor antagonists did not influence the 
migration  of GFAP-negative, fibroblast-like cells (Fig.  8 
D), which is consistent with the lack of NR1 immunoreac- 
tivity and mRNA in these cells (Fig. 2).  Identical results 
were obtained in the absence of serum. Under control con- 
ditions (without NMDA antagonist), an average of 24 _+ 6 
GalC+ cells per explant were counted in the cellular out- 
growth.  In the  presence of d-AP5  (100  p,M), no GalC+ 
oligodendrocytes could be detected in the outgrowth. This 
effect was reproducible in three independent experiments 
that involved the analysis of 19 individual cultures. 
The possible involvement of NMDA receptor in O-2A cell 
migration was further suggested by the effect of high con- 
centrations of Mg  2÷. Since extracellular Mg  2+ blocks NMDA 
receptor activation in a voltage-dependent manner (Nowak 
et al., 1984), it is expected to influence cell migration. In- 
deed, explants maintained in medium containing 3.5  mM 
Mg  2÷, known to effectively block NMDA receptors, resulted 
in a significantly smaller number of migrating cells (Fig. 8 E). 
Figure  7.  The  effect of long-term 
d-AP5  treatment  on  PSA-NCAM 
surface  immunoreactivity  of neuro- 
hypophysial O-2A cells. O-2A cells 
were allowed to migrate in the pres- 
ence of PDGF/NT3 (10 ng/ml)  for 
2 d and were maintained in the pres- 
ence or absence of 100 IxM d-AP5 for 
an  additional  5  d.  Cultures  were 
then  double  immunostained  for 
PSA  and NCAM.  (Left) PSA im- 
munoreactive  cells  from  control 
and  d-AP5-treated  cultures.  Note 
that  the  PSA  immunostaining  of 
cells  is  markedly  decreased  by 
d-AP5 treatment. (Right) Results of 
the  quantitative  analysis  of  PSA 
and NCAM surface staining as eval- 
uated  by  confocal  laser  micros- 
copy. The figure shows the absolute 
values in  arbitrary units  (mean  --- 
SEM of n  =  5 independent experi- 
ments from 120 cells). The statisti- 
cal comparison of average intensities 
of PSA and NCAM immunoreactivity from five independent experiments indicates no significant differences between homologous ex- 
perimental groups (interexperimental variations are <10%); thus, absolute values obtained in different experiments are comparable. 
Bars, 50 Ixm. 
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sponsible for the inhibition of cell migration, we tested the 
reversibility of the effect of NMDA receptor antagonists. 
Explants were cultured in the presence of 100 p,M d-AP5 
for 3 d, followed by an additional 3 d without d-AP5. The 
number of migrating cells in these cultures  increased by 
five times as compared with that measured at the end of 
the 3-d d-AP5 treatment (Fig. 8 G). However, this number 
was smaller than that measured with untreated  controls, 
confirming our previous observations that the peak of cell 
migration takes place during the first 3 d in vitro (Wang et al., 
1994).  It appears thus that the viability of O-2A lineage 
cells was not significantly influenced by d-AP5. This con- 
clusion is further supported by experiments in which O-2A 
cell populations were kept in the presence d-AP5 for 5 d 
(see below) without noticeable cell death. In another se- 
ries of experiments, we tested the effect of NMDA antago- 
nists  on  the  differentiation  of O-2A  cells  into  GFAP+ 
type 2 astrocytes. O-2A cells were allowed to migrate in 
the presence of PDGF and NT3, and then differentiation 
was  induced  by  addition  of  serum.  The  appearance  o~ 
GFAP+  type 2  astrocytes was not affected by the pres- 
ence  of  NMDA  antagonists  (not  shown).  None  of the 
above-mentioned antagonists seemed to influence GFAP 
or A2B5 immunolabeling in migrating cells. 
To  determine  whether  NMDA  receptor  antagonists 
influence the proliferation rate of O-2A lineage cells, ex- 
plants  were  maintained  in  the  presence of PDGF/NT3 
and exposed to BrdU during the whole ctdture period (3 
d). The number of BrdU-positive cells in the outgrowth 
zone was not different in the presence or absence of d-AP5 
(180  +  22  and  173  _  21  BrdU-labeted cells per explant 
without and with d-AP5, respectively. Hence, it is unlikely 
that NMDA antagonists reduce the number of migrating 
cells by influencing  their proliferation rate. This conclu- 
sion is consistent with our previous results (Wang et al., 
1994), indicating that the majority of migrating O-2A lin- 
eage cells do not incorporate  BrdU in serum-containing 
medium. 
Taken together, these results point to a critical role for 
NMDA receptor activation in O-2A cell migration from 
neurohypophysial explants. 
Discussion 
Our results provide direct evidence for the expression of 
functional NMDA receptors in O-2A lineage cells. More- 
over, they strongly suggest that the activity of these recep- 
tors  participate in  the  regulation  of cell  migration.  This 
may occur via the modulation of the expression of PSA on 
NCAM known to play a critical role in O-2A cell motility. 
This constitutes an example of how interactions between 
ionotropic receptors, intracellular signaling, and cell adhe- 
sion molecule expression influence properties of the cell 
surface, which, in turn,  are a  critical determinant  of cell 
migration  (Rakic  et  al.,  1994).  Most  importantly,  these 
studies suggest a potential mechanism through which neu- 
ronal activity, via neuromediator (glutamate) release, may 
affect glial cell motility during morphogenesis. 
The experiments described in this paper provide several 
lines of evidence for the expression of functional NMDA 
receptors on neurohypophysial O-2A cells. First, we have 
demonstrated the presence of RNA transcripts and immu- 
noreactivity for the NR1 subunit, known to be essential for 
function. NR1 immunoreactivity is exclusively localized in 
A2B5+/O4  +  cells that  displayed the  typical O-2A cell 
morphology. Similarly, the in situ hybridization signal was 
specific to this cell type. In contrast,  A2B5/O4-negative, 
epitheloid  cells  (fibroblasts)  were  consistently  negative. 
We have shown previously that all A2B5+  cells in these 
cultures  belong  to  the  O-2A  cell  lineage  (Wang  et  al., 
1994). Second, using whole-cell patch-clamp recording, we 
have found that application of NMDA induced an inward 
current that had properties similar to the  current  of the 
neuronal NMDA receptor. These include the range of ac- 
tivating concentrations of NMDA (5-100 izM), the block 
by MK-801, and the Mg2+-sensitive rectification of the I/V 
curve in the hyperpolarized potentials. Third, the applica- 
tion of NMDA elicits increases in intracellular Ca  2÷, which 
could be blocked by the specific antagonist d-AP5 as well 
as by perfusing cultures with Ca2+-free solutions or high 
Mg  2+. These properties are different from those described 
in Bergman glia cells in which the NMDA-induced current 
required a high concentration of agonist (1 mM) and dis- 
played a linear current voltage relationship, and the acti- 
vation was not accompanied by detectable changes in cy- 
tosolic Ca  2÷ (Muller et al., 1993). Since NMDA receptors 
in O-2A lineage cells have similar properties to the neu- 
ronal type of NMDA receptors, it is important to exclude 
the possible contamination by neurons. It must be empha- 
sized that there are no neurons in the neurohypophysis in 
vivo (Hatton,  1990),  and we could not detect neurons in 
these cultures. We cannot formally exclude the existence 
of  pluripotent,  neuron/glia  precursors  in  our  cultures. 
Figure 8.  Effect of pharmacological blockade of ionotropic glutamate receptors on the migration of O-2A lineage cells. Cultures were 
maintained in serum-complemented medium for 3 d, fixed, and double immunostained for GFAP and A2B5 as described in Materials 
and Methods.  (A) Low power photomicrograph of a control explant with GFAP-immunolabeled type 2 astrocytes in the outgrowth. 
These cells also display A2B5 immunoreactivity (not shown here, but see Fig. 1, E and F). (B) The addition of the NMDA receptor an- 
tagonist, d-AP5 (100 p,M), to the culture medium almost completely blocks the migration of GFAP-positive cells. (C and D) High power 
photomicrographs of a d-AP5-treated culture.  The presence of d-AP5 does not affect the outgrowth of non-GFAP-positive cells. (E) 
Total number of GFAP-positive cells in the migrating  population under different experimental conditions:  in the presence of d-AP5 
(100 IzM); MK-801 (1 txM); CNQX (20 ixM); Mg  2÷ (3.5 mM); nifedipin  (Ni)') (10 ~M); TI'X (1 tzM); and cyclopiazonic acid (CPA) (10 
~M). Each value is the mean + SEM from n = 3-5 independent experiments expressed as a percentage of the control value (100% = 51 
-- 12 cells per explant).  (F) The dose-dependent effect of NMDA receptor antagonist  d-AP5 on cell migration. Values are the mean -+ 
SEM, from n = 3 independent experiments.  Bars: (A and B) 100 ~m; (C and D) 25 Ixm. (G) Recovery from d-AP-5 treatment. Explants 
treated with d-AP5 for 3 d were allowed to recover in the absence of the antagonist  for an additional  3 d. The cultures were double im- 
munostaiued for GFAP and A2B5 as described in Materials and Methods. The results show the absolute number of GFAP-positive cells 
in the migratory population, and each value is the mean _+ SEM of n = 3 independent experiments. 
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that, if present, these multipotent precursor ceils are likely 
to adopt the O-2A lineage cell fate. Moreover, cells that 
diplayed NMDA-induced currents had a morphology and 
pattern  of voltage-activated currents  characteristic  for 
O-2A cells (Barres et al.,  1990; Blankenfeld et al., 1992). 
Fourth, the pharmacological blockade of NMDA receptors 
specifically inhibited the migration of O-2A cells. 
The expression of NMDA receptors on O-2A cells is un- 
expected since previous studies failed to demonstrate (but 
could not exclude) NMDA receptor expression in these 
cells (Barres et al., 1990; Fulton et al., 1992; Patneau et al., 
1994; Usowicz et al., 1989; Wyllie et al., 1991; Gallo et al., 
1994). One possible explanation for this discrepancy is that 
NMDA  receptor expression is  lineage stage  dependent, 
and O-2A cells obtained from explants are in a different 
developmental  stage  compared  with  other  preparations 
such as dispersed cell cultures. This hypothesis is currently 
being tested in our laboratory. The stage-dependent ex- 
pression of voltage-dependent calcium channels in the O-2A 
cell  lineage  has  been  demonstrated  (Sontheimer  et  al., 
1989; Blankenfeld et al.,  1992).  It has also been suggested 
that the enzymatic isolation of cells used for the prepara- 
tion of dispersed cell cultures selectively destroys NMDA 
receptors (Barres et al., 1990). It is uncertain whether O-2A 
cells  from  neurohypophysis differ from  those  obtained 
from the optic nerve and from other brain  regions. Al- 
though neurohypophysial O-2A cells are similar to O-2A 
cells from other sources in many respects  (Wang  et al., 
1994), most O-2A cells from the neurohypophysis express 
a low level of GFAP immunoreactivity in serum-contain- 
ing medium, in contrast with O-2A cells from other struc- 
tures, such as the optic nerve (Dubois-Dalcq,  1987; Raft, 
1989;  Wang  et al.,  1994).  We have previously proposed 
that pituicytes, the resident astrocytes in the neurohypo- 
physis, may develop from O-2A-like cells; thus, GFAP ex- 
pression of the O-2A cell may be an indication of an in 
vivo commitment toward the astrocytic phenotype (Wang 
et al., 1994). Importantly, our in situ hybridization studies 
indicate  that  the  NR1  subunit  mRNA  is  present  in  the 
neurohypophysis in vivo (Kiss, J.Z., and C. Wang, unpub- 
lished observations). Clearly, further studies are required 
to establish whether the expression of functional NMDA 
receptors  is  a  feature  of oligodendrocyte precursors  in 
general and, if so, whether they are involved in the regula- 
tion of ceil migration in vivo. 
Our results raise the possibility that NMDA receptors 
expressed in neurohypophysial cells may represent homo- 
meric complexes of the NR1 subunits. Previous studies have 
established  that functional characteristics of the NMDA 
receptor are determined by its subunit composition (Mori- 
yoshi et al., 1991; Seeburg et al., 1995). Expression studies 
in oocytes suggest that homomeric complexes of the NR1 
subunit  form functional receptors  (Monyer et  al.,  1992; 
Moriyoshi et al.,  1991;  Seeburg et al.,  1995), which may 
also be present in vivo (Durand et al., 1993; Zhang et al., 
1994). However, the efficiency of this homomeric receptor 
was found to be very low (Moriyoshi et al.,  1991). While 
the NR1 subunit RNA and immunoreactivity were clearly 
detectable in O-2A cells of the neurohypophysis, we were 
unable to demonstrate the presence of the NR2 subunit 
RNAs in these cells, even using a sensitive technique such 
as RT-PCR analysis. The possibility that the homomerlc 
NR1 receptor type is expressed in O-2A cells is consistent 
with the very low increase of intracellular Ca  2÷ elicited by 
NMDA, comparable to that obtained with the homomeric 
NR1 receptors reconstituted in oocytes (Moriyoshi et al., 
1991). Nevertheless, we cannot exclude the possibility that 
the NR1 subunit is combined with a yet unknown subunit 
to form a heteromeric receptor. 
Our study provides evidence for the presence of func- 
tional NMDA receptors on O-2A cells, but we have not 
carried  out  a  detailed  pharmacological  and  molecular 
characterization of the receptor. It is known, for example, 
that at least seven NR1 splice variants (NR1A-G) are ex- 
pressed in the brain, which differ in their spatial and tem- 
poral  expression  patterns  (Laurie  and  Seeburg,  1994), 
their cellular distribution  (Ehlers et al.,  1995), and their 
sensitivity to polyamines, phorbol esters, and Zn  2+  (Du- 
rand et al.,  1993; Hollmann et al., 1993). The probes we 
used  in  this  study recognize a  fragment common to  all 
splice  variants;  thus,  the  possibility  exists  that  different 
spliced isoforms of the NR1 subunit are present in O-2A 
cells. 
Despite moderate increases in cytosolic Ca  z+  concen- 
tration relative to neurons that follows their activation, 
the NMDA receptors on O-2A cells appear to have a criti- 
cal role in the regulation of cell migration. These cells are 
known  to express other Ca  2÷  channels  such  as  voltage- 
dependent Ca  2+ channels and non-NMDA, AMPA/kain- 
ate  receptors  that  were  shown  to  be  Ca  2+  permeable 
(Barres  et al.,  1990;  Borges et al.,  1994;  Patneau  et  al., 
1994; Pende et al., 1994; Wyllie et al., 1991). The presence 
of these channels has also been confirmed by patch-clamp 
recordings as well as by the intracellular calcium measure- 
ments in this study. However, the application of the non- 
NMDA receptor antagonist, CNQX, only caused a moder- 
ate (~40%) decrease of cell migration as opposed to the 
strong  inhibition  (N90%)  obtained  with  the  selective 
NMDA antagonist, d-AP5. This is consistent with the ob- 
servation that CNQX, in contrast with d-AP5, was ineffec- 
tive in preventing PSA-NCAM expression in these cells. 
Similarly, nifedipin, an antagonist to the L-type voltage- 
sensitive  calcium channels  and  cyclopidazonic acid  that 
depletes IP3-sensitive Ca  2÷ stores without affecting Ca  2+ 
channels (Nelson et al., 1994), produced only a small inhi- 
bition of O-2A cell migration.  It appears,  thus,  that  al- 
though the  activation of AMPA/kainate  receptors, volt- 
age-sensitive calcium channels,  and  the  release  of Ca  z+ 
from intracellular stores may contribute to the migration 
of O-2A cells, NMDA receptor-related mechanisms  are 
hierarchically  more  important.  Evaluating  the  NMDA- 
induced current and increase in cytosolic Ca  2+, we cannot 
exclude the possibility that local changes in calcium con- 
centration are underestimated by the whole-cell measure- 
ments of mean intracellular calcium with Fura-2. NMDA 
receptors may be located at specific sites in the cell mem- 
brane of the O-2A cells. Whatever the interpretation, our 
observations provide further support for the idea that in 
addition  to  signal  transduction,  the  NMDA  class  of 
glutamate receptors plays a critical role in morphogenetic 
events in the nervous system, such as synaptic plasticity as- 
sociated  with  long-term  potentiation  (Bliss  and  Collin- 
bridge, 1993; Bourne and Nicoll, 1993), migration of cere- 
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growth (Scheetz and Constantine-Paton, 1994). 
How does the  NMDA  receptor affect cell migration? 
One possibility is that PSA-NCAM expression is a target 
of the signal transduction cascade that follows NMDA re- 
ceptor activation.  This cell adhesion  molecule has  been 
implicated in a number of morphogenetic events such as 
neuroblast  migration  (Ono  et  al.,  1994),  axonal  growth 
(Doherty et al., 1990; Zhang et al., 1992), myelination and 
remyelination (Oumesmar et al., 1995), activity-dependent 
synaptic plasticity, and regeneration (Muller et al., 1994). 
It is of interest that PSA-NCAM expression is associated 
not only with morphogenetic events taking place during 
development but also with brain structures that undergo 
activity-induced morphological  remodeling  in  the  adult 
(Rougon and Figarella-Branger, 1993; Theodosis and Pou- 
lain,  1993).  Thus,  PSA-NCAM  may represent  a  crucial 
link between cell activation, transmembrane signal trans- 
duction, and rapid remodeling of the cell surface. Earlier 
we  have demonstrated  that PSA-NCAM  can be readily 
translocated to the cell surface upon cell activation through 
the Ca2+-dependent exocytotic pathway (Kiss et al., 1994). 
In this study we have shown in O-2A cells that the expres- 
sion of PSA on NCAM depends on NMDA receptor acti- 
vation. The recovery of PSA immunostaining on the sur- 
face of O-2A cells after Endo N treatment requires ~16 h 
as opposed to 1-2 h for the recovery in neurons and 13 cells 
(Kiss et al., 1994). Most likely, different aspects of PSA- 
NCAM  metabolism are  involved in  the  two cases.  The 
rapid reexpression of PSA on the surface of neurons upon 
activation of the regulated  exocytotic pathway probably 
reflects the translocation of a readily mobilizable intracel- 
lular pool of PSA-NCAM that may involve secretory vesi- 
cles (Kiss et al., 1994). In the case of O-2A cells, the time 
course of recovery is more compatible with the biosynthe- 
sis of new PSA-NCAM. Thus, it is reasonable to propose 
that NMDA receptor activity is linked to the biosynthesis 
of PSA-NCAM in progenitor cells. We observed that if the 
long-term blockade of NMDA receptors resulted in a dra- 
matic decrease in expression of PSA, this did not modify 
the immunolabeling for NCAM.  Therefore, it seems un- 
likely that changes in the transcription of NCAM protein 
backbone are primarily involved in this process. The hy- 
pothesis that NMDA receptor activation is involved in the 
polysialylation of NCAM  is  consistent with  recent pub- 
lished data suggesting that Ca  2+ ions and protein kinase C 
play a role in NCAM isoform synthesis and polysialylation 
(Rafuse  and  Landmesser,  1996).  A  potential  target  for 
the observed regulation of PSA-NCAM expression is the 
enzyme polysialyltransferase, recently cloned in hamster 
(Eckhardt  et  al.,  1995)  and  human  (Nakayama  et  al., 
1995), whose RNA transcripts seem to correlate well with 
the formation of PSA in various tissues. The availability of 
probes for detection of the enzyme will allow us to test this 
hypothesis. 
Taken as a whole, our results have interesting implica- 
tions for the physiological role of extraceUular glutamate 
in O-2A cell migration. In vivo, these cells migrate along 
axons, which are able to release glutamate in an activity- 
dependent manner (Chiu and Kriegler, 1994). The affinity 
of NMDA receptors in O-2A cells for agonist is within the 
range  of expected baseline  extracellular glutamate  con- 
centrations. In the neurohypophysis, glial cells are in close 
contact with neurosecretory axons, and the activation of 
these fibers was shown to influence the differentiation and 
motility  of  neurohypophysial  astrocytes  (Hatton,  1990; 
Theodosis and Poulain, 1993). Since neurosecretory termi- 
nals  were  shown  to  contain  glutamate  immunoreactive 
small vesicles (Meeker et al., 1991), glutamate appears to 
be a good candidate to mediate neuron to glia communica- 
tion and to regulate glial cell movement through the acti- 
vation of NMDA receptors and PSA-NCAM expression. 
This hypothesis is consistent with our previous results in 
pituicytes, showing that the  expression of PSA,  but not 
that of NCAM,  requires the presence of neurosecretory 
axons in the neurohypophysis (Kiss et al., 1993). 
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